X4 Pharmaceuticals (XFOR) Price/Sales Ratio
Market Cap: $25.18M
Avg Volume: 76.08K
Industry: Biotechnology
Sector: Healthcare
What is X4 Pharmaceuticals's Price/Sales Ratio?
- X4 Pharmaceuticals's trailing twelve month (TTM) Price/Sales ratio is 9.85.
- X4 Pharmaceuticals's annual Price/Sales ratio as of today is 51920.76.
- X4 Pharmaceuticals's quarterly Price/Sales ratio is 92581.16.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess X4 Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -3545.03
- Quarterly: -833.49
- TTM: -700.63
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 5994.01
- Quarterly: 5994.01
- TTM: 1184.64
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -1014.21
- Quarterly: -4023.68
- TTM: -200.45
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 52.62
- Quarterly: -101.69
- TTM: 5.77
These metrics provide insights into X4 Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
51920.76
Quarterly Price/Sales Ratio
92581.16
TTM Price/Sales Ratio
9.85
X4 Pharmaceuticals Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
X4 Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 51920.76 | -3545.03 | 5994.01 | -1014.21 | 52.62 |
| 2023 | 0.00 | -1326.65 | 2626.53 | -1390.63 | 21.59 |
| 2022 | 0.00 | -604.83 | 766.68 | -736.34 | 10.96 |
| 2021 | 0.00 | -598.32 | 823.89 | -748.45 | -59.83 |
| 2020 | 38728.53 | -1870.01 | 1595.98 | -1975.34 | 49.87 |
| 2019 | 0.00 | -1961.59 | 859.26 | -2310.56 | 24.30 |
| 2018 | 6149.11 | -500.27 | 996.38 | -526.17 | 6.69 |
| 2017 | 0.00 | -698.95 | 403.33 | -849.57 | -2.36 |
| 2016 | 0.00 | -3060.18 | -1243.02 | -3249.11 | -39.95 |
| 2015 | 0.00 | -5319.08 | -2048.47 | -6500.33 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.